RecruitingNCT06316661

CMR Assessment of Cardiac Microvascular Dysfunction in Patients With HFpEF

MAgnetic Resonance Non-contrast Assessment of Cardiac Microvascular Dysfunction in Patients With Heart Failure With PrEserveD Ejection Fraction (MAPPED)


Sponsor

Istituto Auxologico Italiano

Enrollment

60 participants

Start Date

Mar 1, 2019

Study Type

OBSERVATIONAL

Conditions

Summary

Heart failure with preserved ejection fraction (HFpEF) causes hospitalizations, premature mortality and high health care costs. This is also due to poor understanding of HFpEF pathogenesis and, thus, lack of specific therapies. Prompted by the recent demonstration that HFpEF clusters different clinical phenotypes, the investigators propose that these phenogroups are driven by distinct myocardial abnormalities. Cardiac Magnetic Resonance (CMR) can help filling this gap in knowledge: on top of providing gold standard measurements for myocardial volume and cellular mass, recent technical advantages mean that this test can assess and quantify left ventricular extracellular volume, fibrosis and microvascular function accurately and non-invasively. In HFpEF patients, the investigators aim at assessing 1) the coronary microvascular function impairment; 2) the myocardial fibrotic burden; - seeking to understand the disease in order to improve care and cardiovascular outcomes for these patients.


Eligibility

Min Age: 18 Years

Plain Language Summary

Simplified for easier understanding

This study uses cardiac MRI (a detailed heart imaging technique) to evaluate microvascular dysfunction — tiny blood vessel problems inside the heart — in patients with heart failure with preserved ejection fraction (HFpEF), a type of heart failure where the heart pumps normally but is too stiff. Researchers want to understand how these small vessel abnormalities contribute to the condition. **You may be eligible if...** - You are 18 years or older - You have been diagnosed with HFpEF according to 2016 European heart failure guidelines (for the patient group) - You are able to provide written informed consent and safely undergo an MRI **You may NOT be eligible if...** - You are pregnant or breastfeeding - You have absolute contraindications to the MRI procedure (including poorly controlled asthma, severe kidney disease with GFR below 30, or atrial fibrillation) - You have had prior chemotherapy or radiation to the chest - You have known coronary artery disease, diabetes, or systemic inflammatory conditions - You are a control group participant with any known cardiac, lung, blood, or cancer condition Talk to your doctor to see if this trial is right for you.

This is a simplified summary. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

DIAGNOSTIC_TESTstress perfusion cardiac magnetic resonance

stress perfusion cardiac magnetic resonance according to guidelines, with quantitative evaluation for microvascular dysfunction assessment

DIAGNOSTIC_TESTcardiopulmonary exercise test

bike exercise with ECG and non invasive respiratory gas exchange monitoring


Locations(1)

IRCCS Istituto Auxologico Italiano

Milan, Italy

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT06316661


Related Trials